Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (121-130 of 361) with videos related to

Pageof 37
Sort By:
Journal of Cardiac Failure|December 29, 2021
Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC StudySenthil Selvaraj, Brian Claggett, Michelle C Johansen, et al.
Plos Medicine|October 15, 2020
Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysisKanako Teramoto, Mário Santos, Brian Claggett, et al.
The Lancet. Public Health|August 21, 2018
Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysisSara B Seidelmann, Brian Claggett, Susan Cheng, et al.
JACC. Heart Failure|January 24, 2014
Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities)Orly Vardeny, Deepak K Gupta, Brian Claggett, et al.
Circulation|December 28, 2018
Influenza Vaccine in Heart FailureDaniel Modin, Mads Emil Jørgensen, Gunnar Gislason, et al.
Heart (British Cardiac Society)|May 17, 2018
Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapyWilson Nadruz, Erin West, Morten Sengeløv, et al.
European Journal of Heart Failure|September 12, 2018
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trialNadia Bouabdallaoui, Brian Claggett, Michael R Zile, et al.
Journal of the American College of Cardiology|February 21, 2019
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEFMichael R Zile, Eileen O'Meara, Brian Claggett, et al.
Journal of the American College of Cardiology|September 2, 2024
Excess Mortality and Hospitalizations Associated With Seasonal Influenza in Patients With Heart FailureDaniel Modin, Brian Claggett, Niklas Dyrby Johansen, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Cardioprotective effects of antiretroviral treatment in adolescents with perinatal HIV infection are heterogeneous depending on age at treatment initiationItai M Magodoro, Carlos E Guerrero-Chalela, Brian Claggett, et al.
Pageof 37

Showing results (121-130 of 361) with videos related to

Sort By:
Pageof 37
Journal of Cardiac Failure|December 29, 2021
Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC StudySenthil Selvaraj, Brian Claggett, Michelle C Johansen, et al.
Plos Medicine|October 15, 2020
Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysisKanako Teramoto, Mário Santos, Brian Claggett, et al.
The Lancet. Public Health|August 21, 2018
Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysisSara B Seidelmann, Brian Claggett, Susan Cheng, et al.
JACC. Heart Failure|January 24, 2014
Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities)Orly Vardeny, Deepak K Gupta, Brian Claggett, et al.
Circulation|December 28, 2018
Influenza Vaccine in Heart FailureDaniel Modin, Mads Emil Jørgensen, Gunnar Gislason, et al.
Heart (British Cardiac Society)|May 17, 2018
Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapyWilson Nadruz, Erin West, Morten Sengeløv, et al.
European Journal of Heart Failure|September 12, 2018
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trialNadia Bouabdallaoui, Brian Claggett, Michael R Zile, et al.
Journal of the American College of Cardiology|February 21, 2019
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEFMichael R Zile, Eileen O'Meara, Brian Claggett, et al.
Journal of the American College of Cardiology|September 2, 2024
Excess Mortality and Hospitalizations Associated With Seasonal Influenza in Patients With Heart FailureDaniel Modin, Brian Claggett, Niklas Dyrby Johansen, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Cardioprotective effects of antiretroviral treatment in adolescents with perinatal HIV infection are heterogeneous depending on age at treatment initiationItai M Magodoro, Carlos E Guerrero-Chalela, Brian Claggett, et al.
Pageof 37